NCT00105170View on ClinicalTrials.gov

Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Tumors

Interventions

DRUG

hCBE-11

Trial Locations (3)

80045

Research Site, Aurora

85724-5024

Research Site, Tucson

19111-2497

Research Site, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY